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2 with the exception of narrow-spectrum daptomycin and linezolid [4] . At the moment twenty new antibiotics are in clinical trials, but most of these do not have new mechanisms of action [5] .
Bacteria causing food-borne diseases, such as Staphylococcus aureus, Bacillus cereus and
Salmonella enterica, are a major health concern and contribute to significant economic losses globally [6, 7] . Food-poisoning caused by S. aureus is one of the most common food-borne diseases worldwide [7] . In addition, S. aureus causes infections on the skin, endocarditis, pneumonia, osteomyelitis, bacteraemia and central nervous system infections [8] . Methicillin and multi-drug resistant S. aureus (MRSA) is a threat to public health in many regions of the world [9, 10, 11, 12] . Increasing consumption of processed refrigerated foods and the increasing percentage of elderly and immunocompromised people contributes to raise the importance of B. cereus as a causative agent of food-poisonings [13, 14, 15, 16, 17] . To date, B. cereus has typically been found to be resistant only to β-lactams [14] , but resistance against erythromycin and tetracyclines has been reported in USA and Europe [18] . Nontyphoid and typhoid Salmonella infections are of global concern and are complicated by increasing prevalence of acquired multiple drug resistance (MDR) [19, 20, 21] . Non-typhoid Salmonella is one of the most important food-borne pathogens [22] . Salmonella enterica is estimated to cause 1.2 million infections yearly in USA and is the leading cause of hospitalizations and death among food-borne diseases [23, 24] . Floroquinolones and cephalosporins are used for the standard treatment of Salmonellosis, but during the last decade, increasing resistance to ciprofloxacin has been observed [21, 22] .
Pseudomonas aeruginosa is an opportunistic pathogen known to cause a range of infections, including infections in wounds, intra-abdominal and urogenital sepsis as well as pneumonia in immunocompromised individuals and in children suffering from cystic fibrosis [25, 26] . Moreover,
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Systemic infections caused by Candida species are the fourth leading cause of nosocomial infections with high mortality rates, the rates depending on the species of Candida [42] . Candida albicans is still the most frequently isolated agent of candidiasis, but non-albicans Candida species (NAC), such as C. glabrata, C. tropicalis, C. parapsilosis and C. krusei are increasing [43] . Most of the NAC species exhibit primary resistance or reduced susceptibility against currently used antifungals, such as azoles, polyenes and echinocandins [44] .
There is an increasing interest in searching for new antimicrobial compounds from higher plants and other biological sources as synthetic chemical libraries tend to be limited in structural diversity and are therefore poor sources of antimicrobial leads [45] . An important driving force to explore new plants and other organisms for biologically active compounds is also the accelerating pace of habitat destruction and therefore loss of valuable species [46] . Generally higher plants are regarded as a rich source of antimicrobial compounds, among which alkaloids represent a promising class of bioactive compounds [47, 48, 49, 50, 51, 52] . Antimicrobial activity of alkaloids is dependent on the structural class, so that piperidine, pyrrolidine and pumiliotoxine alkaloids have been found to be the most inhibitory [47, 53, 54] .
Norway spruce (Picea abies L. Karsten), one of the most common coniferous species in Northern Europe is a rich source of different compounds [55, 56, 57, 58, 59, 60] . Norway spruce needles and young stems contain a number of small molecular mass piperidine alkaloids, epidihydropinidine and cis-pinidinol being the most abundant ones [55, 56, 61] . Piperidine alkaloids in conifers are thought to be insect antifeedants but have also been reported to be toxic and teratogenic in a frog embryo test [61, 62, 63] . Less is known about their possible role as antifungals and antibacterials. However, extracts of spruce cotyledons have been found to effectively inhibit fungal growth, but the active compounds were not characterized [64] . So far cis-pinidinol was found to be devoid of antibacterial activity, whereas euphococcinine showed weak activity against gram-negative bacteria [61] . However, structurally related synthetic trans-2-methyl-6-n-undecyl (Solenopsine A), -tridecyl (Solenopsine B) and -pentadecyl (Solenopsine C) alkaloids, have been found to give good growth inhibitory effects against gram-positive bacteria [65] . Moreover, piperidine alkaloids in the venom of the fire ant have been proposed to play a protective role against microbial infections of the ant cuticle [66] .
Epidihydropinidine (trans-2-methyl-6-propylpiperidine) present in Norway spruce needles was chosen as the compound to study since, to the best of our knowledge, this piperidine alkaloid has not been studied before for its growth inhibitory effects against human pathogenic bacteria and yeasts. Volatile and water-soluble epidihydropinidine is known to be present in constant concentrations in both young
and mature needles and twigs of Norway spruce [55, 58, 59] . In this study we describe the in vitro growth inhibitory effects of epidihydropinidine, the major piperidine alkaloid in Norway spruce, against selected human pathogenic bacteria and fungal species. Bacillus cereus, Salmonella enterica, Staphylococcus aureus and Pseudomonas aeruginosa were selected according to their ability to induce food poisoning or spoilage of food [7, 67] . In addition, Enterococcus faecalis was chosen as a grampositive model bacterium commonly causing nosocomial infections [68] . The fungal species, Candida albicans and C. glabrata, were selected according to their clinical relevance of being the most frequent causative agents of systemic fungal infections as well as of opportunistic infections in mouth [43, 69] .
Experimental

Extraction and identification of epidihydropinidine from Norway spruce
Biologically relevant concentration of epidihydropinidine was obtained from alkaloid mixture extracted with solid phase partitioning (SPP) method, identified and quantified with GC-MS from the needles and bark of Norway spruce (Picea abies) originating from Eastern Finland [55, 56, 57, 58] .
Synthesis of (±)-Epidihydropinidine
Racemic (±)-epidihydropinidine was synthesized according to [70, 71, 72] . Pure product was identified based on NMR spectra recorded using a Bruker Avance 400 FT NMR spectrometer and EI-MS spectra using an Agilent 6890 gas chromatograph coupled to HP5973 mass selective detector equipped with an HP-1MS column (30 m × 0.25 mm ID, 25-μm film thickness, Agilent Technologies, USA) and G1701DA ChemStation D.00.00.38 software (Agilent Technologies).
1 H NMR, 13 C NMR, COSY, and HSQC identification was performed according to [71] and GC-MS according to [61] .
(±)-Epidihydropinidine ( 
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Antibacterial and antifungal assays
Antimicrobial activity of epidihydropinidine was analyzed with synthetized pure (±)-epidihydropinidine [55, 56] . concentration of (±)-epidihydropinidine or antibiotics. For minimum bactericidal and fungicidal concentration estimations the microplate tests were first performed as described above, after which 100 µl from those wells containing MIC and from wells containing the following four higher concentrations above MIC were pipetted and spread out evenly on petri dishes ( = 9 cm) containing Isosensitest or Saboraud agar as top layer. The petri dishes were incubated for 24-48 h at +37 ˚C. MBC and MFC were expressed as the lowest concentrations of (±)-epidihydropinidine or antibiotics which totally inhibited the growth of the microorganisms after subculturing, resulting in a clear surface of the petri dishes. All assays were done in duplicate, and repeated at least two times and the results were expressed as mean ± standard deviation (SD).
Results
The growth inhibitory effects of ()-epidihydropinidine, a 2,6-disubstituted piperidine alkaloid, of which the (+)-enantiomer ( Fig. 1a) is present as the major piperidine alkaloid in the needles, bark and xylem of Norway spruce, was investigated against bacteria causing food spoilage and food poisonings as well as some other relevant human pathogenic bacteria and two clinically relevant Candida species. ()-Epidihydropinidine showed a broad spectrum of activity, inhibiting the growth of all the tested gram-positive and gram-negative bacteria as well as the Candida species (Table 1) .
Antibacterial effects
In this screening, Pseudomonas aeruginosa was most susceptible of all the tested bacteria to the effects of ()-epidihydropinidine, and the lowest IC50 value of 1.34 µg/mL and a MIC of 5.37 µg/mL could be recorded against this bacterial strain (Table 1 and Fig. 2a ). It is noteworthy that the MIC of ()-epidihydropinidine was nearly three times lower than the MIC of tetracycline (15.63 µg/mL) against P.
aeruginosa (Table 1 and Fig. 2b ). The growth inhibition of ()-epidihydropinidine was dose-dependent and still at 2.68 and 1.34 µg/mL, a 73 % and 52 % growth inhibition could be observed, respectively (Fig. 2a) . For comparison, at 1.95 µg/mL, tetracycline inhibited only 4.5 % of the growth of P.
aeruginosa (Fig. 2b) .
Promising growth inhibitory results were also obtained against the gram-positive Enterococcus faecalis. ()-Epidihydropinidine gave a MIC of 5.37 µg/mL and an IC50 of 2.68 µg/mL against this bacterium and was nearly three times more effective than tetracycline which gave a MIC of 15.63 µg/mL (Table 1, Fig. 3a) . The growth inhibitory effects of ()-epidihydropinidine were dose-dependent
and still at 0.67 µg/mL a 22.68 % inhibition of growth could be observed. At 0.33 µg/mL the growth inhibitory effect increased slightly to 27.69 % but decreased again at 0.16 µg/mL to 20.93 % (Fig. 3a) .
At concentrations below 1.95 µg/ml, however, tetracycline was more effective than ()-epidihydropinidine. For comparison, at 0.24 µg/mL tetracycline inhibited 46.22 % of the growth of E.
faecalis (Fig. 3b) .
In our study ()-epidihydropinidine gave a good dose-dependent growth inhibition against S.
aureus, showing a MIC of 10.75 µg/mL and an IC50 of 5.37 µg/mL ( Fig. 5a ). In comparison, tetracycline and ampicillin gave MIC values of 0.48 and 250 µg/mL, respectively (Table 1 and Fig.   5b ). Thus, the MIC of epidihydropinidine was 23 times lower than the MIC of ampicillin.
S. enterica was most resistant of all the investigated bacteria and fungi against the growth inhibitory effects of ()-epidihydropinidine. Similarly as for the other bacteria the growth inhibition of ()-epidihydropinidine was dose dependent and a decrease of inhibitory effects could be seen with decreasing concentrations (Fig. 6a) . MIC was 43 µg/mL and IC50 16.50 µg/mL (Table 1) . MIC was at the same time also minimum bactericidal concentration (MBC) and this concentration was found to be bactericidal even after two days of incubation. For comparison, tetracycline and ampicillin gave MIC values of 1.95 and 7.81 µg/mL, respectively, against S. enterica (Table 1 , Fig. 6b ).
Antifungal effects
()-Epidihydropinidine gave promising growth inhibitory effects against C. albicans and C.
glabrata, showing MIC and MFC values of 5.37 and 43 µg/mL, respectively, against both fungal species (Table 1) . A sharp decline could be observed in the growth inhibitory effects of ()-epidihydropinidine between MIC and 2.68 µg/mL for both Candida species (Fig. 7a) . At 2.68 and 1.34 µg/mL, no growth inhibition, but a slight growth stimulation was observed for both Candida species. In comparison to ()-epidihydropinidine the antifungal standard drug, amphotericin B, gave a MIC of 0.24 µg/mL against C. albicans (Table 1) and similarly as for ()-epidihydropinidine there was a sharp decline in inhibitory effects at smaller concentrations such as between 0.24 and 0.12 µg/mL (Fig. 7b ).
Amphotericin-B was less active against C. glabrata, showing a MIC of 15.63 µg/mL and thus ()-epidihydropinidine was almost three times more effective.
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Discussion
Our results on the anti-Pseudomonas activity of ()-epidihydropinidine are promising since gram-negative bacteria in general are more resistant to antibiotic agents than gram-positive bacteria due to the presence of an outer lipopolysaccharide (LPS) rich membrane which acts as a permeability barrier, especially for hydrophilic and negatively charged molecules [74, 75, 76, 77, 78] . We suggest that ()-epidihydropinidine, as a relatively hydrophilic water soluble molecule [79] , is exerting its growth inhibitory effects on P. aeruginosa, and other gram-negative bacteria, by travelling through porins, water-filled channels in the outer lipopolysaccharide membrane and reaching possible target in periplasmic space or at inner cell membrane [80] .
There are only a few other studies on the effects of piperidine alkaloids on the growth of P.
aeruginosa and some other gram-negative bacterial species; (+)-euphococcinine, another piperidine alkaloid in spruce, was found to give slight growth inhibition against gram-positive bacteria (MIC 100-1000 µg/mL) but no activity against gram-negative bacteria [61] . In another study [81] , an alkaloid fraction of Piper nigrum fruits was found to be more growth inhibitory against gram-negative than gram-positive bacteria. Moreover, piperine from the fruits of Piper nigrum was antibacterial against P.
aeruginosa giving a MIC of 250 µg/mL [50] . This MIC is, however, 46 times higher than our MIC for ()-epidihydropinidine against P. aeruginosa. Interestingly, in another study piperine, at concentrations of 0.5-10 µg/mL, was found to decrease bacterial swarming and swimming motility in E. coli and increased the penetration of ciprofloxacin and azithromycin in E. coli biofilms [82] . This warrants further studies on the effects of ()-epidihydropinidine on the motility of Pseudomonas aeruginosa, since motility is important for pathogenesis, i.e. the capacity of an infection to spread. Solenopsine A, a piperidine alkaloid from the venom of the fire ant, Solenopsis invicta, has been found to suppress quorum sensing signaling resulting in a decrease in virulence factor production and biofilm formation in P. aeruginosa [83] and the authors of this investigation also hypothesized that piperidine alkaloids containing shorter acyl side chains would be even more effective antagonists of quorum sensing inducers than solenopsine A. This would apply for ()-epidihydropinidine, which has a relatively short acyl chain, and therefore its effects on QS inducers of P. aeruginosa should be investigated.
Our results indicate that ()-epidihydropinidine could be used in very small concentrations to prevent P. aeruginosa and other species of Pseudomonas to cause spoilage of refrigerated, aerobically stored meat [67, 84] . Moreover, ()-epidihydropinidine might be used for treatment of P. aeruginosa
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9 induced bronchial infections in cystic fibrosis patients. However, further studies are needed to clarify possible adjuvant in vitro and in vivo effects of ()-epidihydropinidine and its enantiomers, in combination with conventional antibiotics, among them ciprofloxacin, used for cystic fibrosis. Keeping in mind that there are only few novel agents available with anti-pseudomonad activity [5, 85] aureus by inhibiting the function of efflux pumps [51, 87] . Piperine from the fruits of Piper nigrum and other Piper spp. was shown to give antibacterial activity against S. aureus (MIC 250 µg/mL) [50] and to reduce the MIC of mupirocin fourfold and that of ciprofloxacin eight times against S. aureus Piperine and piperidine in antimicrobial dichloromethane extracts of Piper nigrum were suggested to be the active compounds behind promising growth inhibitory effects against B. cereus (MIC 62.5 µg/mL) and in agreement with our results on ()-epidihydropinidine (MIC 10.75 µg/mL) the extracts were found to be more active than ampicillin [50] . Moreover, a root chloroform extract of Microcos paniculata (Tiliaceae), known to contain 2,3,6-trisubstituted piperidine alkaloids such as microcosamines A and B as well as microgrewiapines [91] , was shown to give growth inhibitory effects against B. cereus, along with some other bacterial species such as Salmonella typhi and Vibrio cholera [92] . In view of the increasing knowledge on the potential pathogenicity of strains of B. cereus, some causing serious central nervous system infections in patients with carcinoma and neutropenia [93, 94] as well as other serious infections [15, 17] , it would be important to find new effective and safe agents for treatment of these infections. Our results demonstrate that ()-epidihydropinidine could be a candidate.
To the best of our knowledge no other plant derived pure piperidine alkaloids have been investigated for their growth inhibitory effects against Salmonellae. Extracts from Piper nigrum were found to exert promising growth inhibitory effects against S. typhimurium and the good growth inhibitory effects were suggested to be due to the piperidine alkaloid piperine [95] . Our results indicate that ()-epidihydropinidine could possibly be used as a food preservative for the inhibition of Salmonellosis. In contrast to our results with epidihydropinidine, lignans and stilbenes in polar extracts of Norway spruce knotwood were found to be devoid of growth inhibitory effects against Salmonella infantis [96] . It seems therefore that epidihydropinidine would be one potential anti-Salmonella compound in Norway spruce.
C. albicans has been reported to be the primary causative agent of candidemia [69] and in view of the increasing resistance of C. albicans to the two gold-standard antifungal drugs, amphotericin-B and fluconazole [97, 98] , our antifungal result for ()-epidihydropinidine is notable. Multi-drug resistance in C. albicans has been reported and is due to expression of ATP binding cassette transporter proteins in the membrane [99] . There is an urgent need for new antifungal compounds against C.
albicans, and ()-epidihydropinidine represents a promising candidate.
In our study ()-epidihydropinidine was nearly three times more active than amphotericin B (MIC 15.63 µg/mL) against Candida glabrata (Table 1 ). This result is especially promising considering that in Europe and the USA, C. glabrata has been reported to be the second most important
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A C C E P T E D M A N U S C R I P T 11 fungal pathogen causing systemic infections after C. albicans [42] and high mortality rates have been described [100] . Amphotericin B is generally applied for primary therapy of severe infections caused by C. glabrata [101] but high MIC values of 25 µg/mL against some strains have been demonstrated in agreement with our results [102, 103] . Moreover, 5 % of nosocomial isolates of C. glabrata have been found to be resistant to caspofungin, a drug belonging to the newest class of antifungals, the echinocandins, which target cell wall synthesis [44] .
Some other piperidine alkaloids in spruce have been screened for growth inhibitory effects against yeasts; euphococcinine was found to lack growth inhibitory effects whereas (-)-pinidinol gave slight inhibition [61] . Haloxyline A and B from Haloxylon salicornicum (Chenopodiaceae), showed better antifungal effects (MIC 65 and 80 µg/mL, respectively) than the standard antifungal drug miconazol (MIC 110 µg/mL) against C. glabrata and C. albicans [104] . However, when compared to our results with ()-epidihydropinidine against both C. albicans and C. glabrata, the haloxylines were still 10-12 times less effective. Moreover, it was found that mycelial growth of the plant pathogenic fungal species, Pythium ultimum was significantly reduced by fire ant venom piperidine alkaloids, which closely resemble epidihydropinidine [105] . Therefore, epidihydropinidine and other structurally closely related piperidine alkaloids seem to have promising potential as scaffolds for new antifungal agents, both against Candida species and filamentous fungi.
Conclusions
()-Epidihydropinidine gives promising broad-spectrum antibacterial and antifungal activities showing growth inhibitory effects against all test organisms in this investigation with the smallest MIC values ranging from 5.37-10.75 µg/mL. Of special significance is the low MIC of 5.37 µg/mL against Pseudomonas aeruginosa, being comparable to the MIC of Tomopenem (4 µg/mL), a new carbapenem compound in clinical trial [106] . Bactericidal and fungicidal effects at concentrations of 43 µg/mL were observed against Salmonella enterica as well as Candida albicans and C. glabrata.
Our results indicate that ()-epidihydropinidine could have special potential as a new active compound or drug adjuvant to be developed against bacterial and fungal infections. It must be noted
here, that since the biological activity usually is highly enantiomer specific, and in coniferous trees, such as Norway spruce, epidihydropinidine appears in the (+)-enantiomeric form [61, 62] , further antimicrobial studies are needed using pure (+)-epidihydropinidine and (-)-epidihydropinidine. In the racemic mixture of epidihydropinidine, which we have used in this investigation, the activity could be ACCEPTED MANUSCRIPT
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Further studies are needed to investigate the toxicity of ()-epidihydropinidine and its enantiomers since piperidine alkaloids in general have been found to be both teratogenic and toxic [61, 107] . The LD50 value for epidihydropinidine has not been determined, but we have found that field voles (Microtus agrestis) seem to be resistant to Norway spruce alkaloids in general [55] .
Mechanistic studies should be carried out to elucidate the action of ()-epidihydropinidine and its enantiomers on drug efflux pumps, cell division, cell wall synthesis and integrity, as well as on biofilm formation. In addition, other piperidine alkaloids in spruce, which have not been studied for their antimicrobial effects should be explored, alone and in combinations with ()-epidihydropinidine.
Synergistic effects of piperidine alkaloids in alkaloid enriched extracts from spruce are possible.
The results on the antimicrobial potential of epidihydropinidine are especially promising in view of the increasing global needs for new and effective broad-spectrum antibiotics, useful for the treatment of antibiotic resistant microbes [108] . 
